tirzepatide children (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects FDA expands use for mounajro
Description
However, Ozempic (another form of semaglutide) and Mounjaro (tirzepatide) are only FDA approved for type 2 diabetes, not weight loss
Tirzepatide as compared with semaglutide for the treatment of obesity
On the annual plan, compounded semaglutide is $99 per month and compounded tirzepatide is $125 per month
Food and Drug Administration in 2024 warned about patients overdosing on GLP-1 drugs
Conclusion Understanding the risks associated with tirzepatide is crucial for ensuring safe and effective weight loss management
However, measuring very small volumes (under 10 units) with a standard insulin syringe becomes imprecise, increasing the risk of dosing errors
